Posted by Michael Wonder on 21 May 2018
Draft report for the post-market review of medicines for pulmonary arterial hypertension
21 May 2018 - The draft report for the post-market review of medicines for pulmonary arterial hypertension is available for public comment to 10 June 2018.
The Department is now inviting submissions from interested stakeholders addressing the draft report to the PBAC for this review. This public consultation process will be open for three weeks.
For further information regarding the review, please refer to the review's web page.
